Search

Your search keyword '"Doglioni, Claudio"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Doglioni, Claudio" Remove constraint Author: "Doglioni, Claudio" Database Springer Nature Journals Remove constraint Database: Springer Nature Journals
50 results on '"Doglioni, Claudio"'

Search Results

2. Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis

5. Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer

6. mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy

7. IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer

13. ASO Visual Abstract: Detecting Somatic Mutations for Well-Differentiated Pancreatic Neuroendocrine Tumors in Endoscopic Ultrasound-Guided Fine Needle Aspiration with Next-Generation Sequencing

14. Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 Cases

16. ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma

17. Parenchymal biopsy in the management of patients with renal cancer

20. Detection of clustered circulating tumour cells in early breast cancer

23. The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial

26. Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis

37. Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe‐affected non‐human primates by intracerebral lentiviral gene therapy

41. Feasibility and yield of a novel 22-gauge histology EUS needle in patients with pancreatic masses: a multicenter prospective cohort study

44. A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen)

Catalog

Books, media, physical & digital resources